News

An extensive analysis shows scant evidence that ketamine or other NMDA receptor agonists reduce chronic noncancer pain but ...
A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions ...
A Cochrane review assessed ketamine and other NMDA receptor antagonists for chronic non-cancer pain. The evidence was low to very low certainty, showing no clear pain relief and potential adverse ...
The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.
A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...
Researchers cautioned that the existing evidence base is too poor to draw any solid conclusions on whether ketamine can help ...
A life-saving treatment of IV ketamine could reverse suicidal depression. It might be approved by the FDA and administered by ...
A strong anesthetic ‘Ketamine’ is normally used in hospital procedures. Ketamine is also used for short-term pain management in hospitals. It works by blocking a brain signal ...
Ketamine is regularly used for the treatment of chronic pain, but a new report shows there is no clear evidence of its benefit.The off-label use of ...
Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...
Who is the ketamine queen that sold fatal drug, causing Matthew Perry death? Here's what to know about ketamine and why ...
"It was like urinating shards of glass. I was in agony. An addiction to ketamine has ruined my life." Nathan, who is now in ...